Topline GRADUAL-3 results found that once-monthly bofanglutide maintained weight loss over 24 weeks after intensive treatment every 2 weeks.
Non-inpatient settings, including ambulatory treatment centers, emergency department observation units, and advanced care at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results